Pharmacology, Toxicology and Pharmaceutical Science
4-Aminopyridine
10%
Adalimumab
12%
Adverse Event
32%
Amentoflavone
10%
Antibiotics
46%
Antiinfective Agent
40%
Antimicrobial Resistance
44%
Azithromycin
15%
Cardiovascular Disease
35%
Chronic Disease
33%
Clinical Trial
11%
Cohort Study
27%
Community Pharmacy
30%
Comorbidity
33%
Congestive Heart Failure
13%
Coronavirinae
16%
COVID-19 Vaccine
25%
Cross Sectional Study
11%
Cross-Sectional Study
100%
Diabetes Mellitus
87%
Diabetic Cardiomyopathy
20%
Diseases
53%
Escherichia coli
16%
Etanercept
13%
FDA Adverse Event Reporting System
18%
Gentamicin
20%
Hemoglobin A1c
16%
Hydroxychloroquine
20%
Infection
16%
Inflammation
11%
Inflammatory Arthritis
10%
Medication Error
17%
Nanoparticle
20%
Orphan Drug
10%
Pandemic
20%
Pharmacotherapy
16%
Pharmacovigilance
10%
Polypharmacy
27%
Prevalence
59%
Pseudomonas aeruginosa
11%
Quinolone Derivative
15%
Randomized Controlled Trial
21%
Retrospective Study
12%
Side Effect
22%
Staphylococcus aureus
11%
Surgical Prophylaxis
11%
Tablet
20%
Transcription Factor Nrf2
20%
Ubidecarenone
10%
Warfarin
20%
Nursing and Health Professions
Antiinfective Agent
21%
Antimicrobial Resistance
20%
Antimicrobial Stewardship
11%
Blood Pressure
30%
Cardiovascular Disease
16%
Chronic Disease
23%
Cohort Analysis
26%
Comorbidity
9%
Confidence Interval
13%
Congestive Heart Failure
10%
Cost Control
10%
Cost Effectiveness Analysis
20%
Cross-Sectional Study
90%
Diabetes Mellitus
43%
Diabetic Cardiomyopathy
10%
Diseases
40%
Emergency Ward
10%
Fampridine
10%
Food and Drug Administration
10%
Hazard Ratio
10%
Health Care
15%
Health Care Cost
20%
Health Care Personnel
24%
Healthcare System
9%
Household
10%
Inflammatory Arthritis
10%
Medication Error
18%
Meta Analysis
20%
Odds Ratio
13%
Outpatient Department
11%
Patient Attitude
10%
Patient Care
11%
Patient Compliance
11%
Perioperative
10%
Polypharmacy
19%
Prevalence
21%
Primary Health Care
21%
Professional Standard
10%
Quality of Life
20%
Quality of Life Assessment
10%
Rheumatoid Arthritis
10%
Study Participant
11%
Surgical Infection
10%
Systematic Review
20%
Systolic Blood Pressure
10%
Telemedicine
25%
Tertiary Care Center
20%
Treatment Outcome
10%
Warfarin
10%
World Health Organization
10%
Medicine and Dentistry
Antiinfective Agent
10%
Bariatric Surgery
5%
Blood Pressure
8%
Care Coordination
5%
Chronic Disease
15%
Cost-Effectiveness Analysis
10%
COVID-19
43%
COVID-19 Vaccination
10%
Cross Sectional Study
15%
Culture Conversion
7%
Diabetes
10%
Diabetes Mellitus
35%
Diabetic Retinopathy
10%
Diseases
9%
Drug Megadose
5%
Drug Resistant Tuberculosis
10%
Emergency Department
10%
Female Genital Tract Cancer
10%
Hazard Ratio
10%
Health Care
7%
Health Care Cost
45%
Health Service
6%
Healthcare Quality
10%
Healthcare Research
10%
Hemoglobin A1c
5%
Lifespan
6%
Medication Error
7%
Multivariate Analysis
6%
Multivariate Logistic Regression Analysis
7%
Outpatient
7%
Patient Care
10%
Patient with Hypertension
10%
Percutaneous Thrombectomy
5%
Primary Health Care
10%
Quality Adjusted Life Year
6%
Quinolone
8%
Quinolone Derivative
10%
Recanalization
6%
Retrospective Cohort Study
10%
Sputum Culture
7%
Sputum Smear
10%
Systematic Review
20%
Systolic Blood Pressure
10%
Tertiary Care
22%
Thromboprophylaxis
10%
Vaccine Hesitancy
10%
